跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Risperdal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Risperdal
Approved
STANDARD
Risperdal
Janssen Pharmaceutica
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
42969f430f3fcf0c
Company
Janssen Pharmaceutica
Type
Standard
Approval Details
Approval Id
42969f430f3fcf0c
Drug Approval Philippines Name
Risperdal
Product Name
Risperdal
Registration Number
DR-XY24871
Brand Name
Risperdal
Generic Name
Risperidone
Dosage Form
Oral Solution
Dosage Strength
1mg/ mL
Manufacturer
Janssen Pharmaceutica
Importer
Johnson & Johnson (Phils.) Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/janssen-pharmaceutica
Issuance Date
16 December 2021
Expiry Date
13 November 2026
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
42969f430f3fcf0c
Type
Standard
Back to Philippines FDA Approvals